I mercati dell'Italia hanno chiuso

RGEN Jan 2025 90.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,92000,0000 (0,00%)
Alla chiusura: 10:55AM EDT
Schermo intero
Chiusura precedente1,9200
Aperto1,9200
Denaro0,7500
Domanda3,9000
Prezzo d'esercizio90,00
Scadenza2025-01-17
Min-Max giorno1,9200 - 1,9200
Contratto - Min-MaxN/D
Volume1
Open Interest61
  • GlobeNewswire

    Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer

    Olivier Loeillot President and Chief Commercial Officer WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE Healthcare Life Sciences